Laura Gillim-Ross, PhD

Dr Gillim-Ross is discipline director for infectious disease immunology at Labcorp and a director in the Department of Science and Technology in Burlington. She previously served as the Technical Director for the Denver Regional Laboratory.

Vincent Ricchiuti, PhD

Dr Ricchiuti joined Labcorp in Dublin, OH as laboratory director and discipline director in immunology in 2015. Prior, Dr Ricchiuti was director of clinical chemistry (including immunology testing) and toxicology at the University of Cincinnati Medical Center (UCMC), and associate professor at the University of Cincinnati, Department of Pathology and Laboratory Medicine at the College of Medicine, in Cincinnati, OH (2012-2015). Dr Ricchiuti was the senior director of clinical biomarkers at Medpace Reference Laboratories, in Cincinnati, OH (2011-2012).

3 key differences between medical screening and diagnostic testing

Since the beginning of the COVID-19 pandemic, the world has become increasingly aware of the importance of testing in healthcare. However, it is important to know the difference between diagnostic testing and screening. Both can help save lives, but screening and diagnostic tests have different use cases and may need to be used together to create an overall picture of your health.

Five ways the pandemic has changed healthcare for the better

Year three of the pandemic has brought its fair share of challenges, but it has also highlighted some positive and impactful changes in healthcare. We’ve identified five ways our healthcare has adapted and improved for the better since the start of the COVID-19 pandemic.

Why confirming your rapid antigen COVID-19 test results with a PCR test is important

At this point, we all probably have either had COVID-19 ourselves or known someone close to us who has had it. Since March 2020, nearly 80 million U.S. residents have had confirmed COVID-19 infections – and many more likely have been infected but without reported tests to confirm. And we’re still battling variants and mutations of the disease.

Chronic kidney disease testing among at-risk adults in the U.S. remains low: Real-world evidence from a national laboratory database

An estimated 37 million Americans have chronic kidney disease (CKD). Nearly 90% do not know about their condition because of low awareness about the importance of CKD testing and diagnosis among practitioners and people at risk for CKD.

Labcorp’s perspective: Responding to SARS-CoV-2 and the next pandemic

The magnitude of the COVID-19 pandemic has tested the limits of the response capacities of governments, public health and healthcare infrastructure, and diagnostic laboratories.

Walgreens expands access to COVID-19 testing services by offering Pixel by Labcorp® At-Home COVID-19 PCR Kits at no cost through curbside and in-store pickup

DEERFIELD, Ill., May 23, 2022 — Walgreens, in collaboration with the U.S. Department of Health and Human Services (HHS) and Labcorp, a leading global life sciences company, today announced a program to make Pixel by Labcorp®[1] COVID-19 at-home PCR collection kits available for curbside and in-store pickup at more than 1,000 stores nationwide. This program is designed to offer customers access to convenient, reliable testing at no cost and with no insurance or eligibility requirements.  This initiative builds on Walgreens collaboration with HHS and Labcorp to offer COVID-19 at-home collection kits nationwide at no cost to individuals who meet clinical guidelines.[2]